Nancy J. Leith

Array ( [id] => 20735608 [patent_doc_number] => 20260144898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-05-28 [patent_title] => GENE EDITING SYSTEMS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 19/376282 [patent_app_country] => US [patent_app_date] => 2025-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30314 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19376282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20486193 [patent_doc_number] => 20260022391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-22 [patent_title] => EXPRESSION SYSTEM FOR PRODUCT MANUFACTURING [patent_app_type] => utility [patent_app_number] => 19/343343 [patent_app_country] => US [patent_app_date] => 2025-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16851 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19343343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20473401 [patent_doc_number] => 20260015620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-15 [patent_title] => SYNTHETIC GENE CLUSTERS [patent_app_type] => utility [patent_app_number] => 19/327026 [patent_app_country] => US [patent_app_date] => 2025-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19754 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19327026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20350075 [patent_doc_number] => 20250346927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-11-13 [patent_title] => METHODS AND COMPOSITIONS FOR MODULATING A GENOME [patent_app_type] => utility [patent_app_number] => 19/272775 [patent_app_country] => US [patent_app_date] => 2025-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 162556 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19272775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20336787 [patent_doc_number] => 20250340907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-11-06 [patent_title] => METHODS AND COMPOSITIONS FOR MODULATING A GENOME [patent_app_type] => utility [patent_app_number] => 19/272711 [patent_app_country] => US [patent_app_date] => 2025-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 148979 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19272711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20288621 [patent_doc_number] => 20250313864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-09 [patent_title] => TYPE V CAS PROTEINS AND APPLICATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 19/232045 [patent_app_country] => US [patent_app_date] => 2025-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61726 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19232045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20165320 [patent_doc_number] => 20250257366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-14 [patent_title] => DNA ORIGAMI ENCODING FOR GENE EXPRESSION AND CONTRANSFECTION [patent_app_type] => utility [patent_app_number] => 19/193742 [patent_app_country] => US [patent_app_date] => 2025-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12339 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19193742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20288620 [patent_doc_number] => 20250313863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-09 [patent_title] => ENGINEERED CIRCULARIZED pegRNAs AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 19/174171 [patent_app_country] => US [patent_app_date] => 2025-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 79433 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19174171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20818709 [patent_doc_number] => 12674171 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-07-07 [patent_title] => Aptamer and ribozyme equilibrium shifting (ARES) RNA circuits and uses thereof [patent_app_type] => utility [patent_app_number] => 19/092639 [patent_app_country] => US [patent_app_date] => 2025-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 53 [patent_no_of_words] => 41582 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19092639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20827460 [patent_doc_number] => 12681020 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-07-14 [patent_title] => Compositions and methods for NK-92 cells expressing native CD16 [patent_app_type] => utility [patent_app_number] => 19/085903 [patent_app_country] => US [patent_app_date] => 2025-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 2527 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19085903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20100511 [patent_doc_number] => 20250230447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-17 [patent_title] => EXPRESSION SYSTEM FOR PRODUCT MANUFACTURING [patent_app_type] => utility [patent_app_number] => 19/066066 [patent_app_country] => US [patent_app_date] => 2025-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15932 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19066066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20050265 [patent_doc_number] => 20250188487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-12 [patent_title] => NON-IMMUNOGENIC CIRCULAR, NON-VIRAL DNA VECTORS [patent_app_type] => utility [patent_app_number] => 19/064383 [patent_app_country] => US [patent_app_date] => 2025-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27747 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19064383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20803877 [patent_doc_number] => 12668774 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-06-30 [patent_title] => Product, system and method of cell cultivation [patent_app_type] => utility [patent_app_number] => 19/028930 [patent_app_country] => US [patent_app_date] => 2025-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 125206 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19028930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20025295 [patent_doc_number] => 20250163517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-22 [patent_title] => METHODS FOR SEQUENCING SAMPLES [patent_app_type] => utility [patent_app_number] => 19/028916 [patent_app_country] => US [patent_app_date] => 2025-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17371 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19028916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20491568 [patent_doc_number] => 12533424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-27 [patent_title] => Supplementation of liver enzyme expression [patent_app_type] => utility [patent_app_number] => 18/959371 [patent_app_country] => US [patent_app_date] => 2024-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 50574 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18959371 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20708061 [patent_doc_number] => 20260132389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-05-14 [patent_title] => MATERIALS AND METHODS FOR REDOSING SUBJECTS RECEIVING GENE INSERTION THERAPEUTICS [patent_app_type] => utility [patent_app_number] => 18/947288 [patent_app_country] => US [patent_app_date] => 2024-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8625 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18947288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19862674 [patent_doc_number] => 20250101460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => Controllable Transcription [patent_app_type] => utility [patent_app_number] => 18/941863 [patent_app_country] => US [patent_app_date] => 2024-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24020 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18941863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20694304 [patent_doc_number] => 20260125710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-05-07 [patent_title] => EUKARYOTE QUADRUPLET EXPANDED DNA (QED) GENETIC CODE [patent_app_type] => utility [patent_app_number] => 18/935529 [patent_app_country] => US [patent_app_date] => 2024-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3305 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18935529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19862630 [patent_doc_number] => 20250101416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF TRANSTHYRETIN AMYLOIDOSIS [patent_app_type] => utility [patent_app_number] => 18/900481 [patent_app_country] => US [patent_app_date] => 2024-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30140 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18900481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19615371 [patent_doc_number] => 20240401051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-05 [patent_title] => TUNING CASCADE ASSAY KINETICS VIA MOLECULAR DESIGN [patent_app_type] => utility [patent_app_number] => 18/805534 [patent_app_country] => US [patent_app_date] => 2024-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30782 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 480 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18805534 [rel_patent_id] =>[rel_patent_doc_number] =>)